chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling
Clinical narrative: Experienced swelling under both eyes when I woke up this morning.; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 43-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 23Feb2021 15:45 (at the age of 43 years old) (Batch/Lot Number: EN 5318) as single dose for COVID-19 immunisation. Medical history included none. The patient has no known allergies. Concomitant medications included ascorbic acid, betacarotene, biotin, capsicum annuum fruit, colecalciferol, collagen marine, curcuma longa, cysteine hydrochloride, equisetum arvense, fallopia japonica, hyaluronic acid, iodine, keratin, lysine, methionine, piper nigrum, selenium, serenoa repens, tocotrienols nos, withania somnifera, zinc (NUTRAFOL), vitamin d3, iron, ascorbic acid (VITAMIN C ACID), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]). No other vaccines were received in fourweeks. On 25Feb2021 06:15 AM, the patient experienced swelling under both eyes when she woke up. The patient took benadryl (did not help) but ice pack helped. The patient was not diagnosed with COVID-19 prior to the vaccination and has not been tested for COVID-19 since the vaccination. Therapeutic measures were taken as a result of experienced swelling under both eyes when i woke up this morning. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, SARS-CoV-2 test
Clinical narrative: Arm and armpit pain; Arm joint in back hurts; Arm joint in back hurts; This is a spontaneous report from a non-contactable consumer (reported for herself). An elderly female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in arm right on 05Feb2021 at 10:00 as dose 1, single for covid-19 immunisation at Other. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient has no reported allergies. On an unspecified date in 2021, the patient experienced arm and armpit pain and arm joint in back hurts. The reporter stated the events result in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Nov2020. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Lip swelling
Clinical narrative: The swelling seems to be worsening just to the point where I look unnatural.; I noticed my lips seemed extra full; The swelling seems to be worsening; This is a spontaneous report from a contactable consumer (patient). A 48-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN5918), via an unspecified route on 10Feb2021 at 11:15 (at the age of 48-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history included mild hypertension, arthritis from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL8982), via an unspecified route on 20Jan2021 at 01:00 as dose 1, single in the left arm for covid-19 immunisation and received Juvederm in her cheeks and lips since Oct2020. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, it was unknown the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Feb2021 at 05:00, the patient experienced swelling seems to be worsening just to the point where she look unnatural. Patient stated that with the fact that she had facial fillers. She believe Juvederm. Have had it in her cheeks and lips since Oct2020. One week after her second dose, she noticed her lips seemed extra full. She did not think anything of it but then remembered that the person who did facial fillers mentioned there were some reported issues after vaccine. The swelling seems to be worsening just to the point where she look unnatural. She plan to contact her healthcare provider tomorrow to see about steroids or something else to hopefully remedy this situation.The patient did not receive treatment for events. The outcome of the events was unknown.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Dizziness, Fatigue, Headache
Clinical narrative: stomach ache; Dizziness; headache; vomiting; fatigue; numbness in fingers; pain at injection site; radiating into shoulder; This is a spontaneous report from a non-contactable consumer (patient). A 47-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6203) via an unspecified route of administration on 18Feb2021 at 13:30 (47-year-old at vaccination) as a Dose number unknown, Single for COVID-19 immunization. The patient's medical history included Sleep apnea, Gastrooesophageal reflux disease. The patient had no known allergies. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID prior to vaccination. The patient was not tested for Covid post vaccination. On 20Feb2021 at 06:30 AM, the patient had experienced dizziness, headache, vomiting, fatigue, stomach ache, numbness in fingers, pain at injection site and radiating into shoulder. The patient had received aspirin as treatment medication for resulted events. The outcome of the events was recovering.  No follow up attempts are Possible. No further information was expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Vaccination site pain, Vomiting
Clinical narrative: stomach ache; Dizziness; headache; vomiting; fatigue; numbness in fingers; pain at injection site; radiating into shoulder; This is a spontaneous report from a non-contactable consumer (patient). A 47-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6203) via an unspecified route of administration on 18Feb2021 at 13:30 (47-year-old at vaccination) as a Dose number unknown, Single for COVID-19 immunization. The patient's medical history included Sleep apnea, Gastrooesophageal reflux disease. The patient had no known allergies. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID prior to vaccination. The patient was not tested for Covid post vaccination. On 20Feb2021 at 06:30 AM, the patient had experienced dizziness, headache, vomiting, fatigue, stomach ache, numbness in fingers, pain at injection site and radiating into shoulder. The patient had received aspirin as treatment medication for resulted events. The outcome of the events was recovering.  No follow up attempts are Possible. No further information was expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Chills, Headache
Clinical narrative: moderate headache; Joint pain; Chills; Some chest burning; This is a spontaneous report from a contactable nurse (patient). A 48-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 19Feb2021 (Batch/Lot Number: EN6201) as dose 2 single (at the age of 48-year) for covid-19 immunisation. Medical history included Non-Hodgkin's lymphoma. Concomitant medication included st. john's wort, ergocalciferol (VIT D) at 5000 iU, fluoxetine hydrochloride (PROZAC), cefixime (FLEXERIL [CEFIXIME]). Patient did not have covid prior vaccination. Patient was not tested for Covid post vaccination. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After second dose the patient had joint pain, chills, moderate headache and some chest burning on an unspecified date of 2021. Outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Ear pain, Headache, Musculoskeletal stiffness, Pain
Clinical narrative: significant pain down entire left arm(burning pain) including underarm area/Moderate pain also traveled to right arm; Body aches; joint pain; dull headache; all over skin tenderness; stiff neck; ear pain; This is a spontaneous report from a non-contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 18Feb2021 at 14:00 (at the age of 38-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was reported as none. Known allergies were reported as none. The patient's concomitant medications in two weeks were reported as none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 28Jan2021 at 14:00 (at the age of 38-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, no other vaccine in four weeks was reported. No COVID prior vaccination and no COVID tested post vaccination. On 19Feb2021 at 12:00 AM, the patient experienced significant pain down entire left arm (burning pain) including underarm area. Moderate pain also traveled to right arm as well but not as significant as left arm. Body aches, joint pain, dull headache, all over skin tenderness, stiff neck, ear pain, no fever. Treatment was not received for the events. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pain of skin
Clinical narrative: significant pain down entire left arm(burning pain) including underarm area/Moderate pain also traveled to right arm; Body aches; joint pain; dull headache; all over skin tenderness; stiff neck; ear pain; This is a spontaneous report from a non-contactable consumer (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 18Feb2021 at 14:00 (at the age of 38-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history was reported as none. Known allergies were reported as none. The patient's concomitant medications in two weeks were reported as none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 28Jan2021 at 14:00 (at the age of 38-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, no other vaccine in four weeks was reported. No COVID prior vaccination and no COVID tested post vaccination. On 19Feb2021 at 12:00 AM, the patient experienced significant pain down entire left arm (burning pain) including underarm area. Moderate pain also traveled to right arm as well but not as significant as left arm. Body aches, joint pain, dull headache, all over skin tenderness, stiff neck, ear pain, no fever. Treatment was not received for the events. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Headache, Incoherent, Paraesthesia, Pyrexia
Clinical narrative: I lost the ability to form coherent sentences; On Friday morning the fever was at 103.2F and stayed high; strange tingling sensation in my right arm; strong headache; This is a spontaneous report from a contactable other hcp (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on 18Feb2021 at 1:45 PM as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced lost the ability to form coherent sentences, on Friday morning the fever was at 103.2F and stayed high, strange tingling sensation in right arm, strong headache. It was reported by the patient that "I received my second shot of the Pfizer COVID vaccine on Thursday at 1:45 pm. Approximately 12 hours following the shot I developed a fever. On Friday morning the fever was at 103.2F and stayed high until that evening. In addition, I lost the ability to form coherent sentences, had a strange tingling sensation in my right arm at times (but did not lose muscle control), and developed a strong headache (not a migraine, my migraines usually come with an aura). The fever started to recede by Friday evening, my speech seemed normal again Saturday morning and the headache finally receded by noon on Saturday." The patient underwent lab tests and procedures which included body temperature: 103.2 Fahrenheit on an unspecified date. The clinical outcome of "strange tingling sensation in my right arm" was unknown, while the outcome of other events was recovering.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Feeling abnormal, Headache, Hypoaesthesia
Clinical narrative: arm injection site was tingling; numbing to her fingertips; bruise to the top of her hand; headache; nauseous; pain at the injection site; feeling yucky; tiredness; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date were not reported), via an unspecified route of administration in arm on 24Feb2021 as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that, she had her first dose of the Pfizer-BioNTech COVID-19 vaccine yesterday. The caller stated that, she left and it takes 20 minutes for her to get home and back to work and then her arm injection site was tingling with numbing to her fingertips. The caller stated that, she got to work and it was so busy she jumped in working, then a little while later saw she had a bruise to the top of her hand where the wrist meets the top of where her hand starts, about the size of a fifty cent piece. Stated that, she knows she didn't hit it, she would have felt the tingling if she had. Stated that, her bruise was starting to go away. Stated that, she called her pharmacy and they suggested for her to go to the urgent care, which she did. Stated that, the urgent care said they hadn't heard about bruise like this. Stated that, she also has a headache, was nauseous, has pain at the injection site, was feeling yucky and has tiredness. The caller stated that, the provider at the urgent care suggested and stated that, she had the injection and chose to take the next day off work and that she had same symptoms though she didn't have a bruise. No further details provided about provider that had side effects. The outcome of the events for bruise to the top of her hand was recovering while for the other events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain, Vaccination site paraesthesia
Clinical narrative: arm injection site was tingling; numbing to her fingertips; bruise to the top of her hand; headache; nauseous; pain at the injection site; feeling yucky; tiredness; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date were not reported), via an unspecified route of administration in arm on 24Feb2021 as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that, she had her first dose of the Pfizer-BioNTech COVID-19 vaccine yesterday. The caller stated that, she left and it takes 20 minutes for her to get home and back to work and then her arm injection site was tingling with numbing to her fingertips. The caller stated that, she got to work and it was so busy she jumped in working, then a little while later saw she had a bruise to the top of her hand where the wrist meets the top of where her hand starts, about the size of a fifty cent piece. Stated that, she knows she didn't hit it, she would have felt the tingling if she had. Stated that, her bruise was starting to go away. Stated that, she called her pharmacy and they suggested for her to go to the urgent care, which she did. Stated that, the urgent care said they hadn't heard about bruise like this. Stated that, she also has a headache, was nauseous, has pain at the injection site, was feeling yucky and has tiredness. The caller stated that, the provider at the urgent care suggested and stated that, she had the injection and chose to take the next day off work and that she had same symptoms though she didn't have a bruise. No further details provided about provider that had side effects. The outcome of the events for bruise to the top of her hand was recovering while for the other events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joints got really hurt; This is a spontaneous report from a Pfizer-sponsored program COVAX US SUPPORT. A contactable female consumer  reported for her sister that:       A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) ,dose 1 via an unspecified route of administration on an unspecified date as Dose 1, Single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.On an unspecified date reporter stated that her sister's joints got really hurt after receiving her COVID-19 shot. The outcome of event was unknown..  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body height, Body temperature, Chills, Pain
Clinical narrative: Weakness; Shaking; Generalized aching; Injection site pain; Chills; Fever; This is a spontaneous report form a contactable consumer (Patient) reported that. A 79-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 11:15 (Batch/Lot Number: EL9267; Expiration Date: May2021) as SINGLE DOSE for covid-19 immunization(Age at vaccination 79 years). The patient past Medical history included gastroesophageal reflux disease from an unknown date and unknown if ongoing Blood pressure high (Caller says that she was put on a blood pressure medication 10-15 years ago for this). The concomitant medication was none. Caller says that she was fine that afternoon she had her second dose, which was at 11:15AM. She says that later she hurt bad and could barely move, had a fever of 101-102 degrees Fahrenheit on unspecified date in Feb2021, and nothing else. She says that the pain with her muscles had never hurt like that before, which went on that night and the next day she is better, today she is kind of weak and feels knocked out today. She says her arm was sore but that was not bad, she exercised it and it was fine. She says she just ached and throbbed all over, and couldn't lay any way comfortably, she got hot and had chills and shakes that went on a big part of the night to the next day on 23Feb2021. She says that last night she slept well and feels better she is just beat and kind of weak. Caller says that she has been taking Tylenol then finally took Advil, which she doesn't like to take Advil because she has stomach problems, but they brought her fever down and she feels better. Caller says that she doesn't have those medications with her to provide UIPC/LOT/EXP she says she recently got them, and they were relatively new on the store shelf. No further details provided about the Tylenol or Advil. The event outcome was Unknown for weakness and recovering for rest of the events.  No follow-up attempts are possible. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination site pain, Weight
Clinical narrative: Weakness; Shaking; Generalized aching; Injection site pain; Chills; Fever; This is a spontaneous report form a contactable consumer (Patient) reported that. A 79-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 11:15 (Batch/Lot Number: EL9267; Expiration Date: May2021) as SINGLE DOSE for covid-19 immunization(Age at vaccination 79 years). The patient past Medical history included gastroesophageal reflux disease from an unknown date and unknown if ongoing Blood pressure high (Caller says that she was put on a blood pressure medication 10-15 years ago for this). The concomitant medication was none. Caller says that she was fine that afternoon she had her second dose, which was at 11:15AM. She says that later she hurt bad and could barely move, had a fever of 101-102 degrees Fahrenheit on unspecified date in Feb2021, and nothing else. She says that the pain with her muscles had never hurt like that before, which went on that night and the next day she is better, today she is kind of weak and feels knocked out today. She says her arm was sore but that was not bad, she exercised it and it was fine. She says she just ached and throbbed all over, and couldn't lay any way comfortably, she got hot and had chills and shakes that went on a big part of the night to the next day on 23Feb2021. She says that last night she slept well and feels better she is just beat and kind of weak. Caller says that she has been taking Tylenol then finally took Advil, which she doesn't like to take Advil because she has stomach problems, but they brought her fever down and she feels better. Caller says that she doesn't have those medications with her to provide UIPC/LOT/EXP she says she recently got them, and they were relatively new on the store shelf. No further details provided about the Tylenol or Advil. The event outcome was Unknown for weakness and recovering for rest of the events.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Urine analysis
Clinical narrative: blood in his urine; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program.  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 02Feb2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, the patient has blood in his urine, received first dose 02Feb. The patient underwent lab tests and procedures which included urine analysis: blood in his urine on an unspecified date. The outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache; fatigue; fever; chills; muscle aches; nausea; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-year-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9267) via an unspecified route of administration, administered in arm left on 17Feb2021 12:30 (at the age of 31-year-old) at dose 2, single for covid-19 immunisation. Medical history was reported as none. Patient had no Known allergies. Patient did not have covid prior vaccination. Patient did not have other vaccine in four weeks. Patient was not tested for covid post vaccination. Concomitant medications included levonorgestrel (MIRENA); spironolactone (SPIRONOLACTONE) 25 mg tablet; escitalopram (ESCITALOPRAM) (Other medications in two weeks). Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262) via an unspecified route of administration, administered in Arm Left on 27Jan2021 12:30 (at the age of 31-year-old) at dose 1, single for covid-19 immunisation. On 18Feb2021 03:30 the patient experienced headache, fatigue, fever, chills, muscle aches, nausea. Patient did not receive treatment for the adverse events. Out-come of the events was resolved on an unspecified date in 2021.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; fatigue; fever; chills; muscle aches; nausea; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-year-old (non-pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9267) via an unspecified route of administration, administered in arm left on 17Feb2021 12:30 (at the age of 31-year-old) at dose 2, single for covid-19 immunisation. Medical history was reported as none. Patient had no Known allergies. Patient did not have covid prior vaccination. Patient did not have other vaccine in four weeks. Patient was not tested for covid post vaccination. Concomitant medications included levonorgestrel (MIRENA); spironolactone (SPIRONOLACTONE) 25 mg tablet; escitalopram (ESCITALOPRAM) (Other medications in two weeks). Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262) via an unspecified route of administration, administered in Arm Left on 27Jan2021 12:30 (at the age of 31-year-old) at dose 1, single for covid-19 immunisation. On 18Feb2021 03:30 the patient experienced headache, fatigue, fever, chills, muscle aches, nausea. Patient did not receive treatment for the adverse events. Out-come of the events was resolved on an unspecified date in 2021.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, SARS-CoV-2 test
Clinical narrative: The very next day I had a significant loss in my taste; The very next day I had a significant loss in my  smell.; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 49-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 03Feb2021 14:15 (at the age of 49 years old) (Batch/Lot Number: EM9810) as single dose for COVID-19 immunisation. Medical history included none and the patient has no known allergies. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), levothyroxine sodium (SYNTHROID), trazodone. No other vaccines were received in four weeks. The very next day of vaccination on 04Feb2021 at 12:00 PM she had a significant loss in taste and smell. The events resulted in Doctor or other healthcare professional office or clinic visit. No treatment was received for the adverse events. The patient was not tested for Covid-10 prior vaccination and was tested negative post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 05Feb2021. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia
Clinical narrative: Ache on the arm; Slight fever, it was 99.8; This is a spontaneous report from a contactable consumer (Patient).  A Patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6201), via unspecified route of administration, on unspecified date as a dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: Unknown), via unspecified route of administration, on unspecified date as a dose 1, single for COVID-19 immunization. Patient was informed about Pfizer Medical Information Department. Patient reported that they had COVID and their second COVID vaccination was yesterday, this morning other than a small ache on the arm, patient had a slight fever, it was 99.8 and patient was wondering if patient was contagious. Patient queried for going to the church this morning. Patient were probed if patient had any discomfort from first dose, it was reported that patient had not felt anything. The outcome for the Ache on the arm and Slight fever, it was 99.8 was unknown. Follow-up attempts are completed. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Dyspnoea, Musculoskeletal chest pain, Oropharyngeal discomfort, Pelvic pain
Clinical narrative: trouble with my throat; Stabbing pain under my arms, under my ribs, in my pelvic area. It's like they are so quick it comes like spasm it's like a jabby pain/such a sharp pain it kind of takes your breath away; Stabbing pain under my arms, under my ribs, in my pelvic area. It's like they are so quick it comes like spasm it's like a jabby pain/such a sharp pain it kind of takes your breath away; Stabbing pain under my arms, under my ribs, in my pelvic area. It's like they are so quick it comes like spasm it's like a jabby pain/such a sharp pain it kind of takes your breath away; Stabbing pain under my arms, under my ribs, in my pelvic area. It's like they are so quick it comes like spasm it's like a jabby pain/such a sharp pain it kind of takes your breath away; This is a spontaneous report from a contactable consumer, the patient. A 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration in the arm left on 20Feb2021 as dose 2, single (at the dose of 80-years-old) for covid-19 immunization. The patient had medical history and concomitant medications but she was not willing to report it. It was reported that after the second vaccine yesterday (20Feb2021), on 21Feb2021, she woke this morning at 03:30 and she had pain and it was such an unusual. The patient did not ever have anything like this, it was stabbing pain under arms, under ribs, in pelvic area. It was like they were so quick it comes like spam it was like a jabby pain and it lasted for few sends but it just rotates. The patient had sharp pain it kind of took breath away, it was kind of stabbing like it pokes you with pen or something then it goes and move around, and it was back again. The patient also had trouble with throat and they gave Benadryl, right after the shot. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: wanted to know if she can take Benadryl to prevent her allergies; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient wanted to know if she can take Benadryl to prevent her allergies before she goes to the facility where she can get the second dose. The outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lethargy, Migraine, Myalgia
Clinical narrative: lethargy; Joint pain/aches; muscle pain; headache/migraine; nausea; headache/migraine; persistent thirst; This is a spontaneous report from a contactable consumer (patient). A 31 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3247), via an unspecified route of administration in Left Arm on 24Feb2021 at 13:15 as a Dose 2, single for COVID-19 immunization. The patient's medical history included Heart murmur, history of lyme disease, kenyan tick typhus, known allergies to Sulfa drugs, red dye. The patient's concomitant medication(s) included biotin supplement, melatonin, Multivitamin (unspecified) within two weeks after vaccination. Facility type vaccine was reported as Other. The patient had no Covid infection prior vaccination. The patient was not tested to Covid post vaccination. The patient had not received any other vaccine four weeks prior to Covid-19 vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247) via an unspecified route of administration in Left arm on 04Feb2021 at 09:00 AM, as a Dose 1, Single for COVID-19 immunization. On 25Feb2021 at 11:00, the patient had experienced lethargy, joint pain/aches, muscle pain, headache/migraine, nausea, persistent thirst. No treatment received for resulted events. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Thirst
Clinical narrative: lethargy; Joint pain/aches; muscle pain; headache/migraine; nausea; headache/migraine; persistent thirst; This is a spontaneous report from a contactable consumer (patient). A 31 years old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3247), via an unspecified route of administration in Left Arm on 24Feb2021 at 13:15 as a Dose 2, single for COVID-19 immunization. The patient's medical history included Heart murmur, history of lyme disease, kenyan tick typhus, known allergies to Sulfa drugs, red dye. The patient's concomitant medication(s) included biotin supplement, melatonin, Multivitamin (unspecified) within two weeks after vaccination. Facility type vaccine was reported as Other. The patient had no Covid infection prior vaccination. The patient was not tested to Covid post vaccination. The patient had not received any other vaccine four weeks prior to Covid-19 vaccination. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247) via an unspecified route of administration in Left arm on 04Feb2021 at 09:00 AM, as a Dose 1, Single for COVID-19 immunization. On 25Feb2021 at 11:00, the patient had experienced lethargy, joint pain/aches, muscle pain, headache/migraine, nausea, persistent thirst. No treatment received for resulted events. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Heart rate
Clinical narrative: Chills; fever greater than 101 degrees; tired; fast heart beat; nausea; shortness of breath; This is a spontaneous report from a contactable consumer (patient). This 59-year-old non pregnant female consumer received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EL9266), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:00 as DOSE 2, SINGLE for covid-19 immunisation (Age at vaccination 59 Years). The patient medical history was not reported. Concomitant medication(s) included celecoxib (CELEXA [CELECOXIB]). Historical vaccine includes dose 1 bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EN5318) on 25Jan2021 10:30 AM on Right arm. No other vaccine in four weeks. No Covid prior vaccination. No Covid tested post vaccination. No known allergies. On 20Feb2021 02:30 patient experienced chills, fever greater than 101 degrees, tired, fast heartbeat, nausea, shortness of breath. The patient underwent lab tests and procedures which included body temperature: 101 on 20Feb2021 fever greater than 101 degrees, body temperature: greater on 20Feb2021 fever greater than 101 degrees, heart rate: fast on 20Feb2021 fast heartbeat. The outcome for all events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Nausea, Pyrexia
Clinical narrative: Chills; fever greater than 101 degrees; tired; fast heart beat; nausea; shortness of breath; This is a spontaneous report from a contactable consumer (patient). This 59-year-old non pregnant female consumer received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EL9266), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 12:00 as DOSE 2, SINGLE for covid-19 immunisation (Age at vaccination 59 Years). The patient medical history was not reported. Concomitant medication(s) included celecoxib (CELEXA [CELECOXIB]). Historical vaccine includes dose 1 bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EN5318) on 25Jan2021 10:30 AM on Right arm. No other vaccine in four weeks. No Covid prior vaccination. No Covid tested post vaccination. No known allergies. On 20Feb2021 02:30 patient experienced chills, fever greater than 101 degrees, tired, fast heartbeat, nausea, shortness of breath. The patient underwent lab tests and procedures which included body temperature: 101 on 20Feb2021 fever greater than 101 degrees, body temperature: greater on 20Feb2021 fever greater than 101 degrees, heart rate: fast on 20Feb2021 fast heartbeat. The outcome for all events was recovering.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Neck pain
Clinical narrative: pain on both shoulders, the back of her neck; pain on both shoulders, the back of her neck; extremely tired; This is a spontaneous report from a contactable consumer (patient herself) via Pfizer sponsored program. A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for Covid-19 immunisation. Patients medical history and concomitant medications were not reported. The patient was done with the first dose 11 days ago and up until now she was experiencing pain on both shoulders, the back of her neck and feeling extremely tired, on an unspecified date. The outcome of events was unknown.   Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Maybe a wet cough; This is a spontaneous report from a contactable consumer. A 88-year-old male patient (consumer's father) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 20Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that reporter's father was 88 years old and he had the first dose of the Pfizer vaccine "yesterday", so he had a cough already and (distorted voice) it appear that the cough now was kind of more of a 'loop' cough maybe a wet cough it was not a constant cough and regular but it was about 30 minutes in between maybe longer but reporter was wondering was that something you should to be concerned with and should we have him with that. Reporter stated, Okay reporter have provided that twice already. So, the number that you just gave me these are the people that probably can answer reporter's question that if we should be concerned about his cough. They are answering reporter's question about the COVID vaccine or they are answering reporter's question that should we be concerned, was this a possible side effect or something. Reporter stated, "the number of the vaccine?" Okay so reporter's sister took him, she has that, and reporter do not have that. The reporter stayed with him last night just to make sure you know that he did not have any side effect. The reporter's other sister took him, and she has that card. The outcome of the event was unknown.  Information for Batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, Vaccination site swelling
Clinical narrative: tiredness; fever; headache; muscle pain; injection site swelling; This is a spontaneous report from a Pfizer-sponsored program COVAX US Support via a contactable Other-HCP (Patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: unknown) via an unspecified route of administration on 20Feb2021 as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history were not reported. On an unspecified date in 2021, patient experienced tiredness, fever, headache, muscle pain, and injection site swelling. Outcome of the events were unknown.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Malaise, Myalgia
Clinical narrative: Injection site pain; tiredness; muscle pain; chills; joint pain; feeling unwell; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A patient (Age: 73; Unit: unknown) of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm right on 20Feb2021 at 14:30 (02:30 PM) as dose 1, single for COVID-19 immunization. The patient medical history included COVID-19 (If COVID prior vaccination: Yes) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within four weeks. Patient was diagnosed with COVID prior vaccination. Patient had not COVID tested post vaccination. On 20Feb2021 at 12:00 AM, the patient experienced injection site pain, tiredness, muscle pain, chills, joint pain, feeling unwell. The patient did not receive treatment for the events. Outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number could not be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site pain; tiredness; muscle pain; chills; joint pain; feeling unwell; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A patient (Age: 73; Unit: unknown) of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm right on 20Feb2021 at 14:30 (02:30 PM) as dose 1, single for COVID-19 immunization. The patient medical history included COVID-19 (If COVID prior vaccination: Yes) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within four weeks. Patient was diagnosed with COVID prior vaccination. Patient had not COVID tested post vaccination. On 20Feb2021 at 12:00 AM, the patient experienced injection site pain, tiredness, muscle pain, chills, joint pain, feeling unwell. The patient did not receive treatment for the events. Outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number could not be obtained. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: With both doses soreness in the left arm.; mild fever; general achiness; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration at arm left (at the age of 43-year-old) on 20Feb2021 10:00 (Lot Number: EL9264) as single dose for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient did not have COVID prior vaccination. The patient had not tested COVID post vaccination. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration at arm left (at the age of 43-year-old) on 30Jan2021 15:00 (Lot Number: EN9581) as single dose for COVID-19 immunisation and experienced soreness in left arm. The patient with both doses had soreness in the left arm and after the second dose had mild fever and general achiness on 21Feb2021 02:00 (AM). The patient did not received treatment for events. The outcome of events was recovering.   Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: nose bleeding; This is a spontaneous report received from a contactable consumer (patient) via Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 17Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that he got the 1st dose of Covid 19 Vaccine last 17Feb and the day after that, he got nose bleeding (18Feb2021). The clinical outcome of event was unknown.  Follow-up attempts completed. No further information expected.